IntroMedic マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Yong Seok Cho

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

Mar 11

IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

Jan 17

What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Nov 24

CEO（最高経営責任者

Yong Seok Cho

less than a year

在職期間

Yong Seok Cho is Chief Executive Officer and President of IntroMedic Co., Ltd.

IntroMedic マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

IntroMedic Co., Ltd., Annual General Meeting, Mar 25, 2021

Recent updates

IntroMedic Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99975 million.

IntroMedic Co., Ltd. has filed a Follow-on Equity Offering in the amount of KRW 999.99975 million.

IntroMedic Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.9978 million.

Full year 2020 earnings released: ₩262 loss per share (vs ₩893 loss in FY 2019)

DSP Corporation entered into an agreement to acquire EMnI Co., Ltd. (KOSDAQ:A083470) from Hans Eng Corp. and IntroMedic Co., Ltd. (KOSDAQ:A150840) for KRW 3.1 billion.

IntroMedic Co., Ltd. announced that it expects to receive KRW 19.99999982 billion in funding from AMB 2000DC WON INC. and another investor

IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

New 90-day low: ₩2,095

New 90-day low: ₩2,275

IntroMedic Co., Ltd., Annual General Meeting, Mar 25, 2021

New 90-day low: ₩2,850

IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

New 90-day high: ₩3,560

What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

New 90-day high: ₩3,020

IntroMedic Co., Ltd. announced that it has received KRW 4.5 billion in funding from FIT Technology Co., Ltd., and another investor

New 90-day low - ₩1,970

CEO（最高経営責任者

在職期間

IntroMedic マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

IntroMedic Co., Ltd., Annual General Meeting, Mar 25, 2021

Recent updates

IntroMedic Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99975 million.

IntroMedic Co., Ltd. has filed a Follow-on Equity Offering in the amount of KRW 999.99975 million.

IntroMedic Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.9978 million.

Full year 2020 earnings released: ₩262 loss per share (vs ₩893 loss in FY 2019)

DSP Corporation entered into an agreement to acquire EMnI Co., Ltd. (KOSDAQ:A083470) from Hans Eng Corp. and IntroMedic Co., Ltd. (KOSDAQ:A150840) for KRW 3.1 billion.

IntroMedic Co., Ltd. announced that it expects to receive KRW 19.99999982 billion in funding from AMB 2000DC WON INC. and another investor

IntroMedic's (KOSDAQ:150840) Stock Price Has Reduced 68% In The Past Three Years

New 90-day low: ₩2,095

New 90-day low: ₩2,275

IntroMedic Co., Ltd., Annual General Meeting, Mar 25, 2021

New 90-day low: ₩2,850

IntroMedic (KOSDAQ:150840) Is Carrying A Fair Bit Of Debt

New 90-day high: ₩3,560

What Type Of Returns Would IntroMedic's(KOSDAQ:150840) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

New 90-day high: ₩3,020

IntroMedic Co., Ltd. announced that it has received KRW 4.5 billion in funding from FIT Technology Co., Ltd., and another investor

New 90-day low - ₩1,970

CEO（最高経営責任者

在職期間

マネジメント基準チェック /04